MOLECULES OF THE MILLENNIUM
Year : 2014  |  Volume : 5  |  Issue : 2  |  Page : 175-178

Lorcaserin: A novel antiobesity drug


Department of Pharmacology, Armed Forces Medical College, Pune, Maharashtra, India

Correspondence Address:
Dick B. S. Brashier
Department of Pharmacology, Armed Forces Medical College, Pune 411 040, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-500X.130158

Rights and Permissions

Obesity is a major co-morbidity with hypertension and diabetes mellitus. There are few drugs for treatment of obesity like orlistat and recentlty approved drug lorcaserin. Lorcaserin has serotonergic properties and acts as an anorectic. It may cause serious side effects, including serotonin syndrome, particularly when taken with certain medicines that increase serotonin levels or activate serotonin receptors. Although, mainstay and first line of approach of treatment will always remain in having low calorie diet and increase in physical activity. Lorcaserin has come as a new hope to achieve success in treating obese patients but still a long road with further extensive research to be undertaken in the treatment of obesity.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3610    
    Printed110    
    Emailed1    
    PDF Downloaded824    
    Comments [Add]    
    Cited by others 8    

Recommend this journal